Kaj Blennow (Former)
1 – 10 of 254
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
- Contribution to journal › Article
-
Mark
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic
- Contribution to journal › Article
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
-
Mark
The CentiMarker project : Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation
- Contribution to journal › Article
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
- Contribution to journal › Article
-
Mark
Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia
- Contribution to journal › Article
-
Mark
Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
